Truist Financial Forecasts Strong Price Appreciation for Cognex (NASDAQ:CGNX) Stock

Cognex (NASDAQ:CGNX) had its price objective upped by analysts at Truist Financial from $71.00 to $78.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has a “hold” rating on the scientific and technical instruments company’s stock. Truist Financial’s price objective would suggest a potential upside of 13.66% from the company’s previous close.

A number of other brokerages also recently commented on CGNX. Cantor Fitzgerald lifted their target price on shares of Cognex from $76.00 to $84.00 and gave the stock an “overweight” rating in a research note on Friday. JPMorgan Chase & Co. raised shares of Cognex from a “neutral” rating to an “overweight” rating and lifted their price target for the company from $65.00 to $75.00 in a research report on Tuesday, May 26th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $75.00 price objective on shares of Cognex in a research report on Thursday, May 7th. The Goldman Sachs Group restated a “buy” rating and issued a $91.00 target price on shares of Cognex in a research report on Friday. Finally, Robert W. Baird set a $72.00 price target on Cognex in a research note on Friday, May 8th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $75.31.

Cognex Stock Performance

NASDAQ CGNX opened at $68.63 on Friday. The stock’s fifty day moving average is $64.99 and its two-hundred day moving average is $57.09. The firm has a market capitalization of $11.42 billion, a P/E ratio of 66.23 and a beta of 1.49. Cognex has a fifty-two week low of $34.60 and a fifty-two week high of $72.88.

Cognex (NASDAQ:CGNX) last issued its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.03. Cognex had a return on equity of 13.82% and a net margin of 16.05%.The business had revenue of $291.26 million during the quarter, compared to the consensus estimate of $292.10 million. During the same period last year, the company earned $0.25 EPS. The company’s revenue for the quarter was up 16.9% on a year-over-year basis. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, sell-side analysts forecast that Cognex will post 1.48 EPS for the current year.

Insider Activity at Cognex

In related news, VP Darren Marc Long sold 20,252 shares of the stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total value of $1,343,517.68. Following the transaction, the vice president directly owned 3,990 shares of the company’s stock, valued at $264,696.60. This trade represents a 83.54% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Mark Fennell sold 64,873 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $67.05, for a total value of $4,349,734.65. Following the transaction, the insider directly owned 11,263 shares in the company, valued at approximately $755,184.15. The trade was a 85.21% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 224,847 shares of company stock valued at $14,975,098 over the last three months. 1.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Cognex

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. State of Michigan Retirement System increased its stake in Cognex by 0.5% in the 1st quarter. State of Michigan Retirement System now owns 39,853 shares of the scientific and technical instruments company’s stock worth $1,952,000 after purchasing an additional 200 shares in the last quarter. Personal CFO Solutions LLC raised its holdings in shares of Cognex by 3.2% during the first quarter. Personal CFO Solutions LLC now owns 6,793 shares of the scientific and technical instruments company’s stock valued at $333,000 after acquiring an additional 212 shares during the period. World Investment Advisors raised its holdings in shares of Cognex by 3.7% during the first quarter. World Investment Advisors now owns 6,073 shares of the scientific and technical instruments company’s stock valued at $298,000 after acquiring an additional 214 shares during the period. Quadrant Capital Group LLC lifted its position in shares of Cognex by 1.0% in the 4th quarter. Quadrant Capital Group LLC now owns 22,907 shares of the scientific and technical instruments company’s stock valued at $824,000 after acquiring an additional 234 shares in the last quarter. Finally, Essential Partners LLC boosted its stake in Cognex by 12.5% in the 1st quarter. Essential Partners LLC now owns 2,153 shares of the scientific and technical instruments company’s stock worth $105,000 after purchasing an additional 239 shares during the period. Institutional investors and hedge funds own 88.12% of the company’s stock.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.